Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70267 |
ADL 08-0011 HCl
|
||
ADL 08-0011 is an active metabolite of the μ-opioid receptor antagonist alvimopan. It is produced from alvimopan via amide hydrolysis by gut microbiota. ADL 08-0011 is a μ-opioid receptor antagonist (Ki = 0.25 nM). It is selective for μ-opioid receptors over κ- and δ-opioid receptors (Kis = 15.8 and 31.6 nM, respectively). ADL 08-0011 inhibits endomorphin 1-induced inhibition of electrically induced contraction of isolated guinea pig ileum (pA2 = 9.4). In vivo, ADL 08-0011 (0.03-1 mg/kg) reverse... | |||
T20081 |
ADL-08-0011
ADL 08-0011 |
||
ADL-08-0011 is an metabolite of alvimopan. |